Journal of Medicinal Chemistry p. 376 - 380 (1986)
Update date:2022-08-04
Topics:
Mistry
Abraham
Hanin
A chronic deficiency in central cholinergic function has been implicated in a number of neuropsychiatric diseases including Alzheimer's disease. Until recently, animal models that simulate the neurochemical conditions that appear to cause these diseases in humans, as a result of a direct manipulation of the central cholinergic system, were not available. Over the past few years, however, we have been successful in developing a cholinotoxin, 1-ethyl-1-(2-hydroxyethyl)aziridinium chloride (AF64A), which has the potential to serve as a novel compound in developing animal models of human brain disorders in which a cholinergic hypofunction has been implicated. In this paper are described the design, synthesis, and testing of several structural analogues of AF64A as potential cholinotoxins, by evaluating them for their ability to inhibit high-affinity choline transport and their affinity toward brain muscarinic receptors. One of the compounds, 1-cyclopropyl-1-(2-hydroxyethyl)aziridinium chloride was found to have a remarkably high affinity (about 40 times higher than AF64A) toward brain muscarinic receptors.
View MoreContact:+86-571-86491666
Address:SHI XIANG ROAD
Lanzhou huibang biological chemical technology Co., LTD
Contact:0931-7843964
Address:NO.2011,Yannan Road,Chengguan,
Shandong Zhongcheng Barium Salt Co., Ltd
Contact:+86-15725732638
Address:No.29 baoxi road, hi-tech zone, zibo, shandong
Disynthesis Chemical Technology Co. Ltd.
Contact:+86-571-88194596
Address:Dengyun road 380, Gongshu district, Hangzhou city, China
QINGDAO HONG JIN CHEMICAL CO.,LTD.
website:http://www.hongjinchem.com
Contact:+86-532-83657313
Address:2ND Building, 8 Shangqing Road, Qingdao, Shandong Province, China.
Doi:10.1055/s-0037-1609553
(2018)Doi:10.1016/S0022-328X(02)01423-7
(2002)Doi:10.1021/ol026648t
(2002)Doi:10.1016/S0957-4166(00)86117-0
(1991)Doi:10.1002/1521-3765(20020503)8:9<2034::AID-CHEM2034>3.0.CO;2-I
(2002)Doi:10.1002/1099-0682(200208)2002:8<2103::AID-EJIC2103>3.0.CO;2-G
(2002)